List of Excipients in API mesalamine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing mesalamine
Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
---|---|---|---|---|---|
Allergan Inc | DELZICOL | mesalamine | 0023-5853 | DIBUTYL SEBACATE | |
Allergan Inc | DELZICOL | mesalamine | 0023-5853 | FERRIC OXIDE RED | |
Allergan Inc | DELZICOL | mesalamine | 0023-5853 | FERRIC OXIDE YELLOW | |
Allergan Inc | DELZICOL | mesalamine | 0023-5853 | HYPROMELLOSES | |
Allergan Inc | DELZICOL | mesalamine | 0023-5853 | LACTOSE MONOHYDRATE | |
>Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing mesalamine
Company | Ingredient | NDC | Excipient |
---|---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 | DIBUTYL SEBACATE |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 | FERRIC OXIDE RED |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 | FERROSOFERRIC OXIDE |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 | HYPROMELLOSE |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 | LACTOSE MONOHYDRATE |
>Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for mesalamine
Excipient focus: ACETYLTRIBUTYL CITRATE
mesalamine drug variants containing ACETYLTRIBUTYL CITRATE
Company | Ingredient | NDC |
---|---|---|
American Health Packaging | mesalamine | 60687-408 |
Zydus Pharmaceuticals USA Inc | mesalamine | 68382-435 |
Zydus Pharmaceuticals USA Inc | mesalamine | 70710-1543 |
Zydus Lifesciences Limited | mesalamine | 70771-1110 |
Zydus Lifesciences Limited | mesalamine | 70771-1353 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing ACETYLTRIBUTYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: AMMONIA
mesalamine drug variants containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
American Health Packaging | mesalamine | 60687-408 |
Zydus Pharmaceuticals USA Inc | mesalamine | 68382-435 |
Zydus Pharmaceuticals USA Inc | mesalamine | 70710-1543 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing AMMONIA
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: ANHYDROUS CITRIC ACID
mesalamine drug variants containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Aphena Pharma Solutions - Tennessee LLC | mesalamine | 43353-884 |
Physicians Total Care Inc | mesalamine | 54868-6150 |
Bryant Ranch Prepack | mesalamine | 63629-8827 |
Salix Pharmaceuticals Inc | mesalamine | 65649-103 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing ANHYDROUS CITRIC ACID
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: ASPARTAME
mesalamine drug variants containing ASPARTAME
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Aphena Pharma Solutions - Tennessee LLC | mesalamine | 43353-884 |
Physicians Total Care Inc | mesalamine | 54868-6150 |
Bryant Ranch Prepack | mesalamine | 63629-8827 |
Salix Pharmaceuticals Inc | mesalamine | 65649-103 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing ASPARTAME
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: BUTYL ALCOHOL
mesalamine drug variants containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
American Health Packaging | mesalamine | 60687-408 |
Zydus Pharmaceuticals USA Inc | mesalamine | 68382-435 |
Zydus Pharmaceuticals USA Inc | mesalamine | 70710-1543 |
Zydus Lifesciences Limited | mesalamine | 70771-1110 |
Zydus Lifesciences Limited | mesalamine | 70771-1353 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing BUTYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
mesalamine drug variants containing CARBOMER HOMOPOLYMER TYPE B
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Encube Ethicals Private Limited | mesalamine | 21922-045 |
Padagis Israel Pharmaceuticals Ltd | mesalamine | 45802-098 |
ANI Pharmaceuticals Inc | mesalamine | 62559-420 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing CARBOMER HOMOPOLYMER TYPE B
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE
mesalamine drug variants containing CARBOXYMETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine film coated | 0378-7401 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing CARBOXYMETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
mesalamine drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | mesalamine | 0527-3012 |
Major Pharmaceuticals | mesalamine | 0904-6832 |
Northstar Rx LLC | mesalamine | 16714-830 |
A-S Medication Solutions | mesalamine | 50090-4168 |
Golden State Medical Supply Inc | mesalamine | 51407-274 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
mesalamine drug variants containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | mesalamine | 54092-100 |
Takeda Pharmaceuticals America Inc | mesalamine | 54092-476 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing CARNAUBA WAX
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: CASTOR OIL
mesalamine drug variants containing CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | mesalamine | 54092-189 |
American Health Packaging | mesalamine | 60687-703 |
Sun Pharmaceutical Industries Inc | mesalamine | 63304-089 |
Carilion Materials Management | mesalamine | 68151-4769 |
Avera McKennan Hospital | mesalamine | 69189-0189 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing CASTOR OIL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
mesalamine drug variants containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Lannett Company Inc | mesalamine | 0527-3012 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
Major Pharmaceuticals | mesalamine | 0904-6832 |
Northstar Rx LLC | mesalamine | 16714-830 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: CERIC OXIDE
mesalamine drug variants containing CERIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing CERIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: COPOVIDONE K25-31
mesalamine drug variants containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mesalamine | 0591-2245 |
AvKARE | mesalamine | 42291-564 |
Bryant Ranch Prepack | mesalamine | 72162-2231 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing COPOVIDONE K25-31
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: CROSPOVIDONE
mesalamine drug variants containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Aphena Pharma Solutions - Tennessee LLC | mesalamine | 43353-884 |
Bryant Ranch Prepack | mesalamine | 63629-8827 |
Salix Pharmaceuticals Inc | mesalamine | 65649-103 |
Oceanside Pharmaceuticals | mesalamine | 68682-113 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing CROSPOVIDONE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C RED NO. 22
mesalamine drug variants containing D&C RED NO. 22
Company | Ingredient | NDC |
---|---|---|
Aurobindo Pharma Limited | mesalamine | 59651-397 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing D&C RED NO. 22
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
mesalamine drug variants containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Takeda Pharmaceuticals America Inc | mesalamine | 54092-189 |
Carilion Materials Management | mesalamine | 68151-4769 |
Avera McKennan Hospital | mesalamine | 69189-0189 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing D&C YELLOW NO. 10
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: DIACETYLATED MONOGLYCERIDES
mesalamine drug variants containing DIACETYLATED MONOGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
American Health Packaging | mesalamine | 60687-703 |
Sun Pharmaceutical Industries Inc | mesalamine | 63304-089 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing DIACETYLATED MONOGLYCERIDES
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: DIBUTYL PHTHALATE
mesalamine drug variants containing DIBUTYL PHTHALATE
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | mesalamine | 53808-0823 |
Zydus Pharmaceuticals (USA) Inc | mesalamine | 68382-484 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing DIBUTYL PHTHALATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: DIBUTYL SEBACATE
mesalamine drug variants containing DIBUTYL SEBACATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
AvKARE | mesalamine | 42291-563 |
A-S Medication Solutions | mesalamine | 50090-3002 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing DIBUTYL SEBACATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
>Company | >Ingredient | >NDC |
Excipient focus: DIMETHICONE
mesalamine drug variants containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
Aurobindo Pharma Limited | mesalamine | 59651-397 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing DIMETHICONE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
mesalamine drug variants containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Encube Ethicals Private Limited | mesalamine | 21922-045 |
Padagis Israel Pharmaceuticals Ltd | mesalamine | 45802-098 |
ANI Pharmaceuticals Inc | mesalamine | 62559-420 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing EDETATE DISODIUM
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
mesalamine drug variants containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | mesalamine | 46708-724 |
AvPAK | mesalamine | 50268-577 |
Aurobindo Pharma Limited | mesalamine | 59651-397 |
American Health Packaging | mesalamine | 60687-650 |
Alembic Pharmaceuticals Inc | mesalamine | 62332-724 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: ETHYLCELLULOSE
mesalamine drug variants containing ETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
American Health Packaging | mesalamine | 60687-703 |
Sun Pharmaceutical Industries Inc | mesalamine | 63304-089 |
Zydus Pharmaceuticals USA Inc | mesalamine | 68382-452 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing ETHYLCELLULOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: FAT, HARD
mesalamine drug variants containing FAT, HARD
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
Actavis Pharma Inc | mesalamine | 0472-1915 |
Northstar Rx LLC | mesalamine | 16714-245 |
Physicians Total Care Inc | mesalamine | 54868-6147 |
Allergan Inc | mesalamine | 58914-501 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing FAT, HARD
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
mesalamine drug variants containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
Alembic Pharmaceuticals Limited | mesalamine | 46708-724 |
AvPAK | mesalamine | 50268-577 |
Takeda Pharmaceuticals America Inc | mesalamine | 54092-189 |
Aurobindo Pharma Limited | mesalamine | 59651-397 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing FD&C BLUE NO. 1
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C GREEN NO. 3
mesalamine drug variants containing FD&C GREEN NO. 3
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Takeda Pharmaceuticals America Inc | mesalamine | 54092-189 |
Carilion Materials Management | mesalamine | 68151-4769 |
Avera McKennan Hospital | mesalamine | 69189-0189 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing FD&C GREEN NO. 3
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 3
mesalamine drug variants containing FD&C RED NO. 3
Company | Ingredient | NDC |
---|---|---|
AvPAK | mesalamine | 50268-577 |
American Health Packaging | mesalamine | 60687-650 |
Ascend Laboratories LLC | mesalamine | 67877-717 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing FD&C RED NO. 3
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: FD&C RED NO. 40
mesalamine drug variants containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | mesalamine | 46708-724 |
Alembic Pharmaceuticals Inc | mesalamine | 62332-724 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing FD&C RED NO. 40
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
mesalamine drug variants containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Lannett Company Inc | mesalamine | 0527-3012 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing FERRIC OXIDE RED
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
>Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
mesalamine drug variants containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Lannett Company Inc | mesalamine | 0527-3012 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
Major Pharmaceuticals | mesalamine | 0904-6832 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing FERRIC OXIDE YELLOW
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
mesalamine drug variants containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing FERROSOFERRIC OXIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: GELATIN
mesalamine drug variants containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
Alembic Pharmaceuticals Limited | mesalamine | 46708-724 |
AvPAK | mesalamine | 50268-577 |
Takeda Pharmaceuticals America Inc | mesalamine | 54092-189 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing GELATIN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: HARD FAT
mesalamine drug variants containing HARD FAT
Company | Ingredient | NDC |
---|---|---|
Sandoz Inc | mesalamine | 0781-7088 |
Camber Pharmaceuticals Inc | mesalamine | 31722-005 |
Greenstone LLC | mesalamine | 59762-0118 |
Bryant Ranch Prepack | mesalamine | 63629-2397 |
Bryant Ranch Prepack | mesalamine | 72162-1804 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing HARD FAT
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
mesalamine drug variants containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
Major Pharmaceuticals | mesalamine | 0904-6832 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing HYPROMELLOSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2208
mesalamine drug variants containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
AvPAK | mesalamine | 50268-577 |
Golden State Medical Supply Inc | mesalamine | 51407-274 |
Aurobindo Pharma Limited | mesalamine | 59651-397 |
American Health Packaging | mesalamine | 60687-650 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing HYPROMELLOSE 2208
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE 2910
mesalamine drug variants containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | mesalamine | 0527-3012 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
AvKARE | mesalamine | 42291-564 |
AvPAK | mesalamine | 50268-577 |
American Health Packaging | mesalamine | 60687-650 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing HYPROMELLOSE 2910
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE PHTHALATE
mesalamine drug variants containing HYPROMELLOSE PHTHALATE
Company | Ingredient | NDC |
---|---|---|
Alembic Pharmaceuticals Limited | mesalamine | 46708-724 |
Alembic Pharmaceuticals Inc | mesalamine | 62332-724 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing HYPROMELLOSE PHTHALATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSES
mesalamine drug variants containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Northstar Rx LLC | mesalamine | 16714-830 |
Golden State Medical Supply Inc | mesalamine | 51407-900 |
Physicians Total Care Inc | mesalamine | 54868-6150 |
Greenstone LLC | mesalamine | 59762-0117 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing HYPROMELLOSES
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
mesalamine drug variants containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
American Health Packaging | mesalamine | 60687-408 |
Zydus Pharmaceuticals USA Inc | mesalamine | 68382-435 |
Zydus Pharmaceuticals USA Inc | mesalamine | 70710-1543 |
Zydus Lifesciences Limited | mesalamine | 70771-1110 |
Zydus Lifesciences Limited | mesalamine | 70771-1353 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing ISOPROPYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: LACTOSE MONOHYDRATE
mesalamine drug variants containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
AvKARE | mesalamine | 42291-563 |
A-S Medication Solutions | mesalamine | 50090-3002 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing LACTOSE MONOHYDRATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
>Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
mesalamine drug variants containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Lannett Company Inc | mesalamine | 0527-3012 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing MAGNESIUM STEARATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
Actavis Pharma Inc | mesalamine | 0472-1915 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID
mesalamine drug variants containing METHACRYLIC ACID
Company | Ingredient | NDC |
---|---|---|
Major Pharmaceuticals | mesalamine | 0904-6832 |
Northstar Rx LLC | mesalamine | 16714-830 |
A-S Medication Solutions | mesalamine | 50090-4168 |
Golden State Medical Supply Inc | mesalamine | 51407-900 |
American Health Packaging | mesalamine | 60687-397 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing METHACRYLIC ACID
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
mesalamine drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Golden State Medical Supply Inc | mesalamine | 51407-274 |
Sun Pharmaceutical Industries Inc | mesalamine | 63304-175 |
Zydus Pharmaceuticals (USA) Inc | mesalamine | 68382-484 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
mesalamine drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
Actavis Pharma Inc | mesalamine | 0472-1915 |
Sandoz Inc | mesalamine | 0781-7088 |
>Company | >Ingredient | >NDC |
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
mesalamine drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5901 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
mesalamine drug variants containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Aurobindo Pharma Limited | mesalamine | 59651-397 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
mesalamine drug variants containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: NONOXYNOL-100
mesalamine drug variants containing NONOXYNOL-100
Company | Ingredient | NDC |
---|---|---|
AvPAK | mesalamine | 50268-577 |
Aurobindo Pharma Limited | mesalamine | 59651-397 |
American Health Packaging | mesalamine | 60687-650 |
Ascend Laboratories LLC | mesalamine | 67877-717 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing NONOXYNOL-100
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
mesalamine drug variants containing PETROLATUM
Company | Ingredient | NDC |
---|---|---|
ANI Pharmaceuticals Inc | mesalamine | 62559-420 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing PETROLATUM
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
mesalamine drug variants containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Major Pharmaceuticals | mesalamine | 0904-6832 |
Northstar Rx LLC | mesalamine | 16714-830 |
A-S Medication Solutions | mesalamine | 50090-3002 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POLYETHYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 3350
mesalamine drug variants containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | mesalamine | 0527-3012 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
AvKARE | mesalamine | 42291-564 |
Chartwell RX LLC | mesalamine | 62135-714 |
Bryant Ranch Prepack | mesalamine | 72162-2213 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POLYETHYLENE GLYCOL 3350
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 400
mesalamine drug variants containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mesalamine | 0591-2245 |
AvKARE | mesalamine | 42291-564 |
AvPAK | mesalamine | 50268-577 |
American Health Packaging | mesalamine | 60687-650 |
Ascend Laboratories LLC | mesalamine | 67877-717 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POLYETHYLENE GLYCOL 400
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 6000
mesalamine drug variants containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
AvKARE | mesalamine | 42291-563 |
Golden State Medical Supply Inc | mesalamine | 51407-274 |
Takeda Pharmaceuticals America Inc | mesalamine | 54092-100 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POLYETHYLENE GLYCOL 6000
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 8000
mesalamine drug variants containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mesalamine | 0591-2245 |
AvKARE | mesalamine | 42291-564 |
Bryant Ranch Prepack | mesalamine | 72162-2231 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POLYETHYLENE GLYCOL 8000
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOLS
mesalamine drug variants containing POLYETHYLENE GLYCOLS
Company | Ingredient | NDC |
---|---|---|
State of Florida DOH Central Pharmacy | mesalamine | 53808-0823 |
Carilion Materials Management | mesalamine | 68151-5652 |
Zydus Pharmaceuticals (USA) Inc | mesalamine | 68382-484 |
Zydus Pharmaceuticals (USA) Inc | mesalamine | 68382-649 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POLYETHYLENE GLYCOLS
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: POLYVINYL ALCOHOL
mesalamine drug variants containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | mesalamine | 0527-3012 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
AvKARE | mesalamine | 42291-564 |
Chartwell RX LLC | mesalamine | 62135-714 |
Bryant Ranch Prepack | mesalamine | 72162-2213 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POLYVINYL ALCOHOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM ACETATE
mesalamine drug variants containing POTASSIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Encube Ethicals Private Limited | mesalamine | 21922-045 |
Padagis Israel Pharmaceuticals Ltd | mesalamine | 45802-098 |
ANI Pharmaceuticals Inc | mesalamine | 62559-420 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POTASSIUM ACETATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM HYDROXIDE
mesalamine drug variants containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
AvKARE | mesalamine | 42291-563 |
Alembic Pharmaceuticals Limited | mesalamine | 46708-724 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POTASSIUM HYDROXIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: POTASSIUM METABISULFITE
mesalamine drug variants containing POTASSIUM METABISULFITE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Encube Ethicals Private Limited | mesalamine | 21922-045 |
Padagis Israel Pharmaceuticals Ltd | mesalamine | 45802-098 |
ANI Pharmaceuticals Inc | mesalamine | 62559-420 |
Bryant Ranch Prepack | mesalamine | 72162-2302 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POTASSIUM METABISULFITE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE
mesalamine drug variants containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
A-S Medication Solutions | mesalamine | 50090-3002 |
A-S Medication Solutions | mesalamine | 50090-3497 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POVIDONE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K30
mesalamine drug variants containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
AvKARE | mesalamine | 42291-563 |
American Health Packaging | mesalamine | 60687-556 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POVIDONE K30
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONE K90
mesalamine drug variants containing POVIDONE K90
Company | Ingredient | NDC |
---|---|---|
Actavis Pharma Inc | mesalamine | 0591-2245 |
AvKARE | mesalamine | 42291-564 |
Bryant Ranch Prepack | mesalamine | 72162-2231 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POVIDONE K90
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: POVIDONES
mesalamine drug variants containing POVIDONES
Company | Ingredient | NDC |
---|---|---|
Carilion Materials Management | mesalamine | 68151-5652 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing POVIDONES
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
mesalamine drug variants containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
AvKARE | mesalamine | 42291-563 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing PROPYLENE GLYCOL
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: SHELLAC
mesalamine drug variants containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
AvKARE | mesalamine | 42291-563 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing SHELLAC
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
>Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
mesalamine drug variants containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Lannett Company Inc | mesalamine | 0527-3012 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing SILICON DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
Actavis Pharma Inc | mesalamine | 0472-1915 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM BENZOATE
mesalamine drug variants containing SODIUM BENZOATE
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Encube Ethicals Private Limited | mesalamine | 21922-045 |
Padagis Israel Pharmaceuticals Ltd | mesalamine | 45802-098 |
ANI Pharmaceuticals Inc | mesalamine | 62559-420 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing SODIUM BENZOATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
mesalamine drug variants containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
AvPAK | mesalamine | 50268-577 |
Aurobindo Pharma Limited | mesalamine | 59651-397 |
American Health Packaging | mesalamine | 60687-650 |
American Health Packaging | mesalamine | 60687-703 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing SODIUM LAURYL SULFATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A
mesalamine drug variants containing SODIUM STARCH GLYCOLATE TYPE A
Company | Ingredient | NDC |
---|---|---|
Lannett Company Inc | mesalamine | 0527-3012 |
Camber Pharmaceuticals Inc | mesalamine | 31722-043 |
Chartwell RX LLC | mesalamine | 62135-714 |
Bryant Ranch Prepack | mesalamine | 72162-2213 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
mesalamine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
Major Pharmaceuticals | mesalamine | 0904-6832 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
>Company | >Ingredient | >NDC |
Excipient focus: STARCH, CORN
mesalamine drug variants containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
American Health Packaging | mesalamine | 60687-703 |
Sun Pharmaceutical Industries Inc | mesalamine | 63304-089 |
Zydus Pharmaceuticals USA Inc | mesalamine | 68382-452 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing STARCH, CORN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: STEARIC ACID
mesalamine drug variants containing STEARIC ACID
mesalamine drug variants not containing STEARIC ACID
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: SUCROSE
mesalamine drug variants containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
American Health Packaging | mesalamine | 60687-703 |
Sun Pharmaceutical Industries Inc | mesalamine | 63304-089 |
Zydus Pharmaceuticals USA Inc | mesalamine | 68382-452 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing SUCROSE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: TALC
mesalamine drug variants containing TALC
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing TALC
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-9230 |
Actavis Pharma Inc | mesalamine | 0472-1915 |
Sandoz Inc | mesalamine | 0781-7088 |
>Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
mesalamine drug variants containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Lannett Company Inc | mesalamine | 0527-3012 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing TITANIUM DIOXIDE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
mesalamine drug variants containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Mylan Pharmaceuticals Inc | mesalamine film coated | 0378-7401 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing TRIACETIN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: TRIETHYL CITRATE
mesalamine drug variants containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
Lannett Company Inc | mesalamine | 0527-3012 |
Actavis Pharma Inc | mesalamine | 0591-2245 |
Upsher-Smith Laboratories LLC | mesalamine | 0832-6056 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing TRIETHYL CITRATE
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: VANILLIN
mesalamine drug variants containing VANILLIN
Company | Ingredient | NDC |
---|---|---|
AvPAK | mesalamine | 50268-577 |
American Health Packaging | mesalamine | 60687-650 |
Ascend Laboratories LLC | mesalamine | 67877-717 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing VANILLIN
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: WATER
mesalamine drug variants containing WATER
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Encube Ethicals Private Limited | mesalamine | 21922-045 |
Padagis Israel Pharmaceuticals Ltd | mesalamine | 45802-098 |
ANI Pharmaceuticals Inc | mesalamine | 62559-420 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing WATER
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
Excipient focus: WHITE WAX
mesalamine drug variants containing WHITE WAX
Company | Ingredient | NDC |
---|---|---|
American Health Packaging | mesalamine | 60687-703 |
Sun Pharmaceutical Industries Inc | mesalamine | 63304-089 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing WHITE WAX
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
>Company | >Ingredient | >NDC |
Excipient focus: XANTHAN GUM
mesalamine drug variants containing XANTHAN GUM
Company | Ingredient | NDC |
---|---|---|
Meda Pharmaceuticals Inc | mesalamine | 0037-0022 |
Meda Pharmaceuticals Inc | mesalamine | 0037-0066 |
Encube Ethicals Private Limited | mesalamine | 21922-045 |
Padagis Israel Pharmaceuticals Ltd | mesalamine | 45802-098 |
ANI Pharmaceuticals Inc | mesalamine | 62559-420 |
>Company | >Ingredient | >NDC |
mesalamine drug variants not containing XANTHAN GUM
Company | Ingredient | NDC |
---|---|---|
Allergan Inc | mesalamine | 0023-5853 |
Allergan Inc | mesalamine | 0023-5901 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-5907 |
Teva Pharmaceuticals USA Inc | mesalamine | 0093-9224 |
Mylan Pharmaceuticals Inc | mesalamine | 0378-1375 |
>Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.